Roberto Miranda

Professor

The University of Texas MD Anderson Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Roberto Miranda is a Professor at the University of Texas MD Anderson Cancer Center, USA. His research encompasses hematopathology, with a focus on lymphoma diagnostics and management, including recent studies on EBV-positive diffuse large B-cell lymphoma and high-grade B-cell lymphoma. He has contributed to advancements in identifying aberrant mast cells in systemic mastocytosis and has explored the complexities of T-cell neoplasms and other related pathologies.

Articles (14)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (8)

Lianqun Qiu

University of Washington

UNITED STATES

View details

Carlos Torres-Cabala

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Luis Malpica

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Shaoying Li

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Julio Chavez

Associate Professor

Moffitt Cancer Center

UNITED STATES

View details

Suzanne Turner

Full Professor

University of Cambridge

UNITED KINGDOM

View details

C. Cameron Yin

UNITED STATES

View details

Phyu Aung

Associate Professor and Director of Surgical Pathology fellowship Program

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Roberto Miranda

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

EBV‐positive diffuse large B‐cell lymphoma, not otherwise specified: 2024 update on the diagnosis, risk‐stratification, and management

Multicolor flow cytometric immunophenotyping is highly sensitive and specific in identifying aberrant mast cells in the diagnostic workup of systemic mastocytosis

Differential Upregulation of Th1/Th17-Associated Proteins and PD-L1 in Granulomatous Mycosis Fungoides

Arterial Thromboembolism in a Patient With Cancer With Unclear Etiology

What’s new in hematopathology 2023: updates on mature T-cell neoplasms in the 5th edition of the WHO classification

High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCL

EBV‐positive diffuse large B‐cell lymphoma, not otherwise specified: 2022 update on diagnosis, risk‐stratification, and management

Primary Lymphomas of the Breast: A Review

Blastoid high-grade B-cell lymphoma initially presenting in bone marrow: a diagnostic challenge

Small cell/lymphohistiocytic morphology is associated with peripheral blood involvement, CD8 positivity and retained T-cell antigens, but not outcome in adults with ALK+ anaplastic large cell lymphoma

Commentary on: Nonmalignant CD30+ Cells in Contralateral Peri-Implant Capsule of Patient With BIA-ALCL: A Premalignant Step?

Mantle cell lymphoma involving tonsils: a clinicopathologic study of 83 cases

The Leukemic Phase of ALK-Negative Anaplastic Large Cell Lymphoma Is Associated with CD7 Positivity, Complex Karyotype, <i>TP53</i> Deletion, and a Poor Prognosis

Anaplastic lymphoma kinase-positive large B-cell lymphoma (ALK + LBCL): a systematic review of clinicopathological features and management

Collaborators (8)

Lianqun Qiu

Carlos Torres-Cabala

Luis Malpica

Shaoying Li

Julio Chavez

Suzanne Turner

C. Cameron Yin

Phyu Aung

Make your next move.